Sustained activation of non-canonical NF-kappaB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL. Lim SK, Peng CC, Low S, Vijay V, et al. Leukemia 2023;37:441-452.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lim SK, Peng CC, Low S, Vijay V, et al. Sustained activation of non-canonical NF-kappaB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL. Leukemia 2023;37:441-452.
PMID: 36446947